Drug Trial Radar · NCT04614103
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Last checked: Nov 20, 2026Latest source record: Jun 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
170
Planned (sponsor's estimate)
Start
May 7, 2021
Primary completion
Dec 2030
Study completion Dec 2031
Sponsor
- Lead sponsor
- Iovance Biotherapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Nov 3, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer
Conditions
- Metastatic Non Small Cell Lung Cancer
Interventions
LN-145Biological
A tumor sample is resected from each patient and cultured ex vivo to expand the population of tumor infiltrating lymphocytes. After lymphodepleting chemotherapy including cyclophosphamide and fludarabine, patient is infused with autologous TIL (LN-145), followed by IL-2.
LN-145Biological
A tumor sample is obtained by image-guided core biopsy from each patient and cultured ex vivo to expand the population of tumor infiltrating lymphocytes. After lymphodepleting chemotherapy including cyclophosphamide and fludarabine, patient is infused with autologous TIL (LN-145) followed by IL-2.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response RateTime frame: Up to 60 months
Locations
71 sites in 12 countries. Site status is shown where the registry gives one.
Banner Health MD Anderson
Gilbert, Arizona · Recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Active not recruiting
H Lee Moffitt Cancer Center and Research Institute
Tampa, Florida · Recruiting
Rush University Medical Center
Chicago, Illinois · Active not recruiting
University of Illinois Hospital & Health Sciences System
Chicago, Illinois · Active not recruiting
Advocate Aurora Health
Park Ridge, Illinois · Recruiting
University of Louisville
Louisville, Kentucky · Recruiting
University of Maryland
Baltimore, Maryland · Active not recruiting
Karmanos Cancer Institute
Detroit, Michigan · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
University of Nebraska Medical Center
Omaha, Nebraska · Recruiting
MD Anderson Cooper
Camden, New Jersey · Recruiting
New York University Langone Medical Center
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
University of North Carolina
Chapel Hill, North Carolina · Recruiting
Novant Health - Winston-Salem
Winston-Salem, North Carolina · Active not recruiting
Sanford Roger Maris Cancer Center
Fargo, North Dakota · Recruiting
University of Cincinnati Medical Center
Cincinnati, Ohio · Recruiting
Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
Oregon Health and Science University
Portland, Oregon · Recruiting
Allegheny General Hospital
Natrona Heights, Pennsylvania · Recruiting
Sanford Cancer Center
Sioux Falls, South Dakota · Recruiting
Avera Medical Group Cancer Institute
Sioux Falls, South Dakota · Active not recruiting
University of Tennessee Medical Center
Knoxville, Tennessee · Recruiting
Baptist Cancer Center
Memphis, Tennessee · Recruiting
VCU Medical Center (Virginia Commonwealth University)
Richmond, Virginia · Recruiting
Seattle Cancer Care Alliance
Seattle, Washington · Recruiting
St. Vincent's Hospital
Darlinghurst, New South Wales, Australia · Recruiting
Westmead Hospital
Westmead, New South Wales, Australia · Recruiting
Hollywood Private Hospital Ramsay
Nedlands, Western Australia, Australia · Recruiting
Centre Hospitalier de l'Universite de Montreal (CHUM)
Montreal, Canada · Recruiting
Institut Paoli Calmettes
Marseille, France · Recruiting
CHU Nantes
Nantes, France · Recruiting
CHU Nice
Nice, France · Recruiting
Centre Hospitalier Lyon Sud
Pierre-Bénite, France · Recruiting
CHRU de Poitiers La Miletrie
Poitiers, France · Recruiting
Gustave Roussy Cancer Campus
Villejuif, France · Recruiting
Charite- Universitätsklinikum Berlin
Berlin, Germany · Recruiting
Universitätsklinikum Carl Gustav Carus, MK I
Dresden, Germany · Recruiting
Universitätsklinikum Frankfurt
Frankfurt, Germany · Recruiting
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.